Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.

Chowell G, Viboud C, Wang X, Bertozzi SM, Miller MA.

PLoS One. 2009 Dec 3;4(12):e8164. doi: 10.1371/journal.pone.0008164.

2.

Modeling optimal age-specific vaccination strategies against pandemic influenza.

Lee S, Golinski M, Chowell G.

Bull Math Biol. 2012 Apr;74(4):958-80. doi: 10.1007/s11538-011-9704-y. Epub 2011 Dec 7.

PMID:
22147102
3.

Optimal pandemic influenza vaccine allocation strategies for the Canadian population.

Tuite AR, Fisman DN, Kwong JC, Greer AL.

PLoS One. 2010 May 6;5(5):e10520. doi: 10.1371/journal.pone.0010520.

4.

Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010.

Blank PR, Bonnelye G, Ducastel A, Szucs TD.

PLoS One. 2012;7(10):e45450. doi: 10.1371/journal.pone.0045450. Epub 2012 Oct 11.

5.

Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.

Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H.

Vaccine. 2011 Jun 20;29(28):4632-7. doi: 10.1016/j.vaccine.2011.04.064. Epub 2011 May 6.

PMID:
21550376
6.

Vaccines against influenza A (H1N1) pandemic.

Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008.

PMID:
20304259
7.

Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico.

Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Tamerius J, Miller MA, Borja-Aburto VH.

PLoS Med. 2011 May;8(5):e1000436. doi: 10.1371/journal.pmed.1000436. Epub 2011 May 24.

8.

Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.

Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, Lipnick R, Vest KG, Russell KL, DeFraites RF, Sanchez JL.

PLoS One. 2010 May 19;5(5):e10722. doi: 10.1371/journal.pone.0010722.

9.

Optimal H1N1 vaccination strategies based on self-interest versus group interest.

Shim E, Meyers LA, Galvani AP.

BMC Public Health. 2011 Feb 25;11 Suppl 1:S4. doi: 10.1186/1471-2458-11-S1-S4.

10.

Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine.

Joshi SR, Shaw AC, Quagliarello VJ.

Yale J Biol Med. 2009 Dec;82(4):143-51. Review.

11.

The transmissibility and control of pandemic influenza A (H1N1) virus.

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.

Science. 2009 Oct 30;326(5953):729-33. doi: 10.1126/science.1177373. Epub 2009 Sep 10.

13.

Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic.

Del Rio C, Hernandez-Avila M.

Arch Med Res. 2009 Nov;40(8):677-80. doi: 10.1016/j.arcmed.2009.12.005. Review.

PMID:
20304256
14.

Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.

Kaboli F, Astrakianakis G, Li G, Guzman J, Donovan T, Naus M.

Infect Control Hosp Epidemiol. 2010 Oct;31(10):1017-24. doi: 10.1086/655465. Erratum in: Infect Control Hosp Epidemiol. 2010 Dec;31(12):1316.

PMID:
20707670
15.

Modelling the effect of seasonal influenza vaccination on the risk of pandemic influenza infection.

Mercer GN, Barry SI, Kelly H.

BMC Public Health. 2011 Feb 25;11 Suppl 1:S11. doi: 10.1186/1471-2458-11-S1-S11.

16.

Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century.

Chang LY, Shih SR, Shao PL, Huang DT, Huang LM.

J Formos Med Assoc. 2009 Jul;108(7):526-32. doi: 10.1016/S0929-6646(09)60369-7. Review.

17.

Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.

Rodríguez-Alvarez M, Velasco-Velasco AM, Alvarez-Anell NJ, Jiménez-Corona ME, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):687-92. doi: 10.1016/j.arcmed.2009.12.002.

PMID:
20304258
18.

Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination.

Choi YS, Baek YH, Kang W, Nam SJ, Lee J, You S, Chang DY, Youn JC, Choi YK, Shin EC.

Clin Vaccine Immunol. 2011 Sep;18(9):1519-23. doi: 10.1128/CVI.05053-11. Epub 2011 Aug 3.

19.

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.

Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002. Epub 2010 Jan 21.

PMID:
20096762
20.

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.

Strengell M, Ikonen N, Ziegler T, Kantele A, Anttila VJ, Julkunen I.

Influenza Other Respir Viruses. 2013 May;7(3):431-8. doi: 10.1111/j.1750-2659.2012.00415.x. Epub 2012 Aug 23.

Items per page

Supplemental Content

Write to the Help Desk